Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Canine Arthritis Treatment Market From 2025 To 2029?

There has been notable growth in recent years in the market size for canine arthritis treatment. The market, which stood at $2.35 billion in 2024, is projected to expand to $2.47 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to the growth during the historic period include a rise in the elderly pet population, heightened awareness among pet owners, emphasis on preventive care, a surge in disposable income, and increased spending on veterinary care.

The market size for canine arthritis treatments is predicted to witness substantial expansion in the ensuing years. With an anticipated expansion to $3.01 billion in 2029 and a compound annual growth rate (CAGR) of 5.0%, this growth in the projected period can be credited to an increased pet insurance coverage, a surge in arthritis cases, a growth in pet ownership, a rising demand for minimally invasive surgeries, and an uptick in the incidence of arthritis in canines. Key trends for the forecast period incorporate cutting-edge therapies, progressions in veterinary medicine, a demand for advanced treatment options, technological integration, and groundbreaking technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What are the Fundamental Drivers and Innovations Shaping the Canine Arthritis Treatment Market?

Advancements in the market for canine arthritis treatment are projected to be boosted by the increased rates of pet ownership. The term “pet ownership” defines the dedication and nurturing provided by individuals or households to meet the requirements, health, and companionship of domesticated animals, mainly kept for enjoyment rather than function. The climb in pet ownership can be linked to factors such as changes in lifestyle, the perception of pets as family members, and augmented disposable income. Canine arthritis treatments are employed by pet owners in order to manage and soothe arthritis symptoms in their dogs, with the goal of enhancing the quality of life and preserving agility in their pets. For example, data from the American Pet Products Association, a non-profit organization based in the U.S., reported that there were 86.9 million US households that owned a pet, equating to 66% of households in 2022, by October 2023. As such, the escalation in pet ownership rates is spurring the growth of the canine arthritis treatment market.

How Is the Canine Arthritis Treatment Market Segmented?

The canine arthritis treatment market covered in this report is segmented –

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis

4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers

2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements

3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy

4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Regions Are Driving the Next Phase of the Canine Arthritis Treatment Market Growth?

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Canine Arthritis Treatment Market?

Leading businesses in the canine arthritis treatment industry are pioneering new therapies, for example, bedinvetmab injections, to manage joint health and mobility in dogs. Bedinvetmab is an injection of monoclonal antibody that mitigates nerve growth factor (NGF) – a protein that is significant in pain management in veterinary medicine. Zoetis Inc., an animal health enterprise based in the US, earned the approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection in May 2023. This is the first FDA approved monoclonal antibody (mAb) for dog use restraining the biological functioning of the nerve growth factor (NGF), which is a key regulator in OA-associated pain. The treatment is a user-friendly, monthly subcutaneous injection, offering a durable resolution for the pain management in canine OA.

View the full report here:

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

How Is the Canine Arthritis Treatment Market Defined and What Are Its Core Parameters?

Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog’s joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model